Indo-American Journal of Pharma and Bio Sciences is an international, online, English-language journal that publishes articles on pharmaceutical and biological sciences of the ugc carelist journals.
This document discusses the debate between randomized clinical trials (RCTs) and observational studies using big data. While RCTs are better for minimizing bias, observational studies can include more patients and answer questions RCTs cannot. The document outlines several large cancer databases that can help learn from every patient, including SEER and NCDB registries. It describes how these databases are being enriched with additional data sources like EHRs, genomic data, and mobile devices. This evolving use of big data from numerous sources can improve outcomes by better understanding toxicity, costs, and quality of cancer care.
Academic doctors' views of complementary and alternative medicine (CAM) and i...home
Despite the caution or scepticism towards CAM expressed by doctors in this study, more open
doctor-patient communication about CAM may enable doctors' potential concerns about CAM to be addressed,
or at least enhance their knowledge of what treatments or therapies their patients are using. Offering CAM to
patients may serve to enhance patients' treatment choices and even increase doctors' fulfilment in their practice.
However, given the recurring concerns about lack of scientific evidence expressed by the doctors in this study,
perceptions of the evidence base may remain a significant barrier to greater integration of CAM within the NHS.
Academic doctors' views of complementary and alternative medicine (CAM) and i...home
This document summarizes an exploratory qualitative study that examined academic doctors' views of complementary and alternative medicine (CAM) and its role within the NHS. Nine academic doctors were interviewed about their perspectives on CAM. The doctors expressed a spectrum of views, from enthusiasm to skepticism. Their professional experiences with both conventional medicine and CAM influenced their attitudes. Key themes that emerged from the interviews included doctor-patient communication about CAM use, the need for CAM training for doctors, a hierarchy of acceptability of different CAM therapies based on evidence, and the potential role of CAM within the NHS. While some doctors expressed caution about CAM due to lack of evidence, more open communication about CAM between doctors and patients could help address concerns or increase doctors' knowledge of
Patient-Reported Outcomes in Cancer Care - Zeena NackerdienZeena Nackerdien
PROs should be integral to evidence-based cancer care. Here I summarize the latest expert opinions on the subject in the form of a conversation between two oncologists. This information should be helpful to healthcare practitioners and patients alike. As always, please consult your own medical doctors for case-by-case advice.
While clinical trials represent leading cancer research, less than 5% of cancer patients enroll due to a lack of awareness and resources. Physicians have little time to enroll patients, and patients and doctors have misconceptions about clinical trials. Molecular targeted trials, based on genetic markers, require less patients than traditional trials to produce meaningful results. Unlike traditional trials, targeted trials do not use placebos and allow switching to tested drugs if beneficial. While complex genetic profiling is required for targeted trials, they provide more personalized treatment with fewer side effects than chemotherapy. Focusing clinical trial searches on predefined molecular markers can help patients find more suitable targeted trials.
The document discusses Peter Embi's approach to presenting on clinical and translational research informatics literature from the past year. It provides an overview of Embi's search strategy and categorization of papers, which involved searching literature databases and recommendations from colleagues. The presentation will focus on summarizing representative papers within categories like data sharing/reuse, methods and systems, recruitment and eligibility, and trends in clinical research informatics.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
This document discusses the debate between randomized clinical trials (RCTs) and observational studies using big data. While RCTs are better for minimizing bias, observational studies can include more patients and answer questions RCTs cannot. The document outlines several large cancer databases that can help learn from every patient, including SEER and NCDB registries. It describes how these databases are being enriched with additional data sources like EHRs, genomic data, and mobile devices. This evolving use of big data from numerous sources can improve outcomes by better understanding toxicity, costs, and quality of cancer care.
Academic doctors' views of complementary and alternative medicine (CAM) and i...home
Despite the caution or scepticism towards CAM expressed by doctors in this study, more open
doctor-patient communication about CAM may enable doctors' potential concerns about CAM to be addressed,
or at least enhance their knowledge of what treatments or therapies their patients are using. Offering CAM to
patients may serve to enhance patients' treatment choices and even increase doctors' fulfilment in their practice.
However, given the recurring concerns about lack of scientific evidence expressed by the doctors in this study,
perceptions of the evidence base may remain a significant barrier to greater integration of CAM within the NHS.
Academic doctors' views of complementary and alternative medicine (CAM) and i...home
This document summarizes an exploratory qualitative study that examined academic doctors' views of complementary and alternative medicine (CAM) and its role within the NHS. Nine academic doctors were interviewed about their perspectives on CAM. The doctors expressed a spectrum of views, from enthusiasm to skepticism. Their professional experiences with both conventional medicine and CAM influenced their attitudes. Key themes that emerged from the interviews included doctor-patient communication about CAM use, the need for CAM training for doctors, a hierarchy of acceptability of different CAM therapies based on evidence, and the potential role of CAM within the NHS. While some doctors expressed caution about CAM due to lack of evidence, more open communication about CAM between doctors and patients could help address concerns or increase doctors' knowledge of
Patient-Reported Outcomes in Cancer Care - Zeena NackerdienZeena Nackerdien
PROs should be integral to evidence-based cancer care. Here I summarize the latest expert opinions on the subject in the form of a conversation between two oncologists. This information should be helpful to healthcare practitioners and patients alike. As always, please consult your own medical doctors for case-by-case advice.
While clinical trials represent leading cancer research, less than 5% of cancer patients enroll due to a lack of awareness and resources. Physicians have little time to enroll patients, and patients and doctors have misconceptions about clinical trials. Molecular targeted trials, based on genetic markers, require less patients than traditional trials to produce meaningful results. Unlike traditional trials, targeted trials do not use placebos and allow switching to tested drugs if beneficial. While complex genetic profiling is required for targeted trials, they provide more personalized treatment with fewer side effects than chemotherapy. Focusing clinical trial searches on predefined molecular markers can help patients find more suitable targeted trials.
The document discusses Peter Embi's approach to presenting on clinical and translational research informatics literature from the past year. It provides an overview of Embi's search strategy and categorization of papers, which involved searching literature databases and recommendations from colleagues. The presentation will focus on summarizing representative papers within categories like data sharing/reuse, methods and systems, recruitment and eligibility, and trends in clinical research informatics.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay.
1) Moffitt Cancer Center provides timely access to a multidisciplinary care team for melanoma patients, allowing diagnosis, staging, and treatment planning to occur in one to two visits. The team reviews pathology reports prior to the first visit to ensure consensus on diagnosis and treatment options.
2) Moffitt streamlines care by having oncologists, dermatologists, surgeons, pathologists, and other providers who are teaching faculty all see patients as part of the comprehensive melanoma care team.
3) Moffitt addresses barriers to care like insurance issues, transportation costs, and travel expenses through dedicated social work support staff to help melanoma patients.
Effectiveness of structured education on safe handling and disposal of chemot...SriramNagarajan16
Aim
To evaluate the effectiveness of structured education on safe handling and disposal of chemotherapeutic drugs among nursing
students
Participants and setting
A pre-experimental one group pre-test – post-test design was adopted for this study. The study was conducted in Vandhana
school of Nursing, Kodhad, telugana, India. The investigator selected 40 nursing students who fulfilled the inclusion criteria
were selected by using simple random sampling technique.
Intervention
Data was collected regarding demographic variable, knowledge and attitude of the diploma in nursing students on safe
handling and disposal of chemotherapeutic drugs.The investigator assessed the level of knowledge and attitude of the
diploma in nursing students by using structured questionnaire and modified three point Likert Scale and by using checklist
through one to one teaching by lecture, demonstration, video clippings and verbalization. Structured teaching programme was
conducted on the same day on group wise each group consists of 17members. Data collection was done in English the
questionnaire was distributed to each nursing students. At the end of the teaching the doubts were cleared. Then 10 minutes
was allotted for discussion.
Measurement and findings
The analysis finding indicates clearly that 36% of students had inadequate knowledge and 46% of them had negative attitude
regarding safe handling and disposal of chemotherapeutic drugs. A well planned structured teaching programme given to the
same group. The effectiveness of programme showed high level of significant at p<0.001 level. It showed that structured
teaching programme was an effective method to improve the knowledge and attitude.
Conclusion
The pharmacist-based interventions improved the knowledge of nursing students in cytotoxic drug handling. Further
assessment may help to confirm the sustainability of the improved practices
This project report summarizes a quantitative analysis of nursing practices related to medication management at XYZ Hospital in Ludhiana, India. The author observed medication administration practices on the hospital's 4th floor over 50 patient cases. The observation found an 18.75% non-compliance rate with best practices, mostly due to staff negligence. Overall, the analysis showed that nursing staff were well-oriented in medication practices, adhering to patients' medication management plans 81.25% of the time. The report recommends continued focus on reducing errors by strictly following medication administration safety guidelines and policies.
This document summarizes the evolution and current state of emergency medicine clinical pharmacists internationally. It describes how their role has expanded from medication distribution to active clinical roles on multidisciplinary teams. Studies show emergency medicine pharmacists can reduce medication errors, mortality, readmissions, and improve time to appropriate treatments. While initially confined to North America, their benefits are now reported internationally. More evidence is still needed on reducing adverse drug events, but existing data shows emergency medicine pharmacists improve patient outcomes and reduce costs.
1) The document discusses improving outcomes and endpoints in cancer trials by better defining what is important to measure, making endpoints more understandable for patients, and advancing endpoints to reflect changes in trial design and treatments.
2) It notes that endpoints need to show clinically relevant benefits to patients, and that improvements in trial design should be accompanied by improvements in available endpoints.
3) Stakeholders including clinicians, patients, and regulators must work together to determine the best approach for research that ensures accountability and optimizes the use of resources.
Conversations About Financial Issues in Routine Oncology Practices: A Multice...Melissa Paige
"We performed qualitative thematic analysis of 529 unique patient encounters from two National Cancer Institue-designated cancer centers and an academic-led county safety-net hospital that were audio recorded prospectively during a three-site communication study"
Use of complementary and alternative medicine by cancer patients at the Unive...home
CAM use is common among cancer patients in Nigeria. Most users do not obtain the
expected benefits, and adverse events are not uncommon. Every clinician in the field of oncology
should ask his/her patients about the use of CAM; this knowledge will enable them to better
counsel the patients
This study assessed the use of complementary and alternative medicine (CAM) among patients in India with four chronic diseases: epilepsy, HIV, rheumatoid arthritis, and diabetes. The researchers surveyed over 4,600 patients and found that 34.7% used CAM. CAM use was highest among diabetes patients (63%) and lowest among epilepsy patients (7.7%). Ayurveda was the most commonly used CAM therapy. The study also assessed patient satisfaction with CAM and found the highest satisfaction for effectiveness and overall among HIV patients, and the lowest among rheumatoid arthritis patients. A large proportion of patients with chronic diseases in India are using CAM and are satisfied with it.
10 STRATEGIC POINTS 2
Ten Strategic Points
Grand Canyon University
DNP-815- O502: Scientific Underpinnings
10 Strategic Points Table
(Use this table to complete the 10 Strategic Points document for your project.)
10 Strategic Points
Comments/Feedback
Broad Topic Area
Impact of Medication Administration Errors on 3-4-Year-old Leukemia Patients
Literature Review
A. Verghese, A., Charlton, B., Kassirer, J. P., Ramsey, M., & Ioannidis, J. P. (2015). Inadequacies of physical examination as a cause of medical errors and adverse events: a collection of vignettes. The American journal of medicine, 128(12), 1322-1324.
The article looks at the “Inadequacies of physical examination as a cause of medical errors and adverse events: a collection of vignettes” from the American journal of medicine. It takes into consideration the fact that, the oversights in the corporeal assessment are a medical fault which aren’t studied via chart evaluation. Furthermore, the article states that these oversights in the corporeal assessments may be the primary contributors to the neglected or late diagnosis besides unnecessary exposure to contrast as well as radiation on the Leukemia patients. Either the authors indicate that the incorrect treatments resulting from these delays leads to unfavorable results like fainting on the Leukemia patient, lack of appetite on the side of the patient, worsening the Leukemia conditions which eventually can lead to early death of the patient.
B. Hockings, J. K., Owolabi, D. K., Broyles, J. E., & Wheelis, S. C. (2017). Impact of medication administration error on over 3 years Leukemia patients and the stimulating factors in acute leukemia and stem cell transplant patients. Supportive Care in Cancer, 25(6), 1853-1858.
The authors of this article explored the “Impact of medication administration error on over 3 years Leukemia patients and the stimulating factors in acute leukemia and stem cell transplant patients.” This article is from supportive care in cancer and it was retrieved from Google Scholar. The article authors acknowledge the fact that, the medication administration errors lead to severe impacts on the health conditions of the patient more especially the ones who are 3 – 4 years of Leukemia. According to the authors, the impacts associated with the medication administration errors may lead to worsening of the health condition of the patient, the rate of Leukemia advancement into higher stages may also increase with treatment or managing of this deadly disease being more complicated. The authors argue that using erroneous medicines, the Leukemia advancement increases without the knowledge of the patient which makes even the survival chances of the patient to reduce due to stress upon realizing that there was an error in his or her medication.
C. Douer, D. (2016). Efficacy and safety of vincristine sulfate liposome injection in the treatment of adult acute lymphocytic leukemia. The oncologist, 21(7), 840-847.
...
A Study on Patient Satisfaction towards Cancer Hospitalijtsrd
A cancer diagnosis places considerable stress on patients and their families. They find themselves discomfort with the strange health system making serious decisions with long term consequences living with uncertainness about the nature, cause and indefinite progress of the disease living with a disrupted family, work, social life and facing the possibility of becoming increasingly dependent on others. Dhivya. S | Harshath. S "A Study on Patient Satisfaction towards Cancer Hospital" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-6 , October 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29274.pdf Paper URL: https://www.ijtsrd.com/management/consumer-behaviour/29274/a-study-on-patient-satisfaction-towards-cancer-hospital/dhivya-s
Observational research can impact clinical decision making for cancer treatment by providing real-world evidence to complement randomized controlled trials, which have limitations. Observational studies capture long-term outcomes of various treatments in everyday practice. However, their findings are more susceptible to bias. To strengthen observational research, standards are needed for electronic health data collection and reporting, while prioritizing patient privacy and rigorous methodologies. With these improvements, observational data can better inform estimates of cancer progression and treatment effects.
This document describes the development and validation of a clinical knowledge measurement tool to assess community pharmacists' ability to detect and resolve drug-related problems (DRPs). The tool consists of 9 clinical cases with multiple choice questions. It was administered to pharmacy students and community pharmacists in Australia. The tool showed good internal consistency and differentiated knowledge levels between student year groups as expected. Pharmacists' scores also correlated with their actual rate of documenting clinical interventions in practice, indicating the tool is effective at estimating pharmacists' ability to detect and resolve DRPs.
Knowledge and attitudes towards complementary and alternative medicine among ...home
The document summarizes a study that examined medical students' knowledge and attitudes toward complementary and alternative medicine (CAM) in Turkey. The study found that the majority of the 943 medical students surveyed were familiar with common CAM methods like herbal treatment, acupuncture, and massage. Most students had positive attitudes toward CAM and expressed willingness to receive training in it. Attitudes declined as students progressed in their medical education. Overall, there was support for integrating CAM into the medical curriculum in Turkey.
Skin Cancer Screening
IMPORTANT NOTE TO USERS OF WEBSITE & DOCUMENTS POSTED ON SLIDESHARE- Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
www.globalmedicalcures.com
Participation of the population in decisions about their health and in the pr...Pydesalud
Póster presentado por Lilisbeth Perestelo en el congreso Summer Institute for Informed Patient Choice (SIIPC14) celebrado del 25 al 27 de junio de 2014 en Dartmouth, Hanover (EEUU). Web: http://siipc.org
Contacto: lperperr@gobiernodecanarias.org
The survey of over 2,800 undergraduate students at UC Irvine found:
1) 35% had used some form of CAM in the past 12 months, and over 90% believed CAM can be effective. However, only 31% had received prior education on CAM.
2) The most common CAM therapies used were supplements, massage, body movement like yoga, herbal medicine, and traditional Chinese medicine.
3) Factors associated with higher CAM use included being female, Asian ethnicity, and having prior CAM education. Most students said they would be interested in CAM courses if they fulfilled graduation requirements or were in their major.
4) The study supports that education is a key factor in CAM use decisions
Objective: To evaluate the utility of a targeted lecture in improving FP awareness amongst clinicians.
Design: This is a dual institution, prospective survey-based study assessing if an educational lecture can increase the likelihood of FP consideration, discussion, and referral.
This document lists publications by Ari Gnanasakthy related to patient-reported outcomes in clinical trials and health economics evaluations. It includes 22 publications ranging from 2005 to 2010 related to establishing minimally important differences in patient-reported outcomes, developing guidance for collecting patient-reported data, evaluating the cost-effectiveness of drugs like valsartan and rivastigmine, and methods for conducting economic evaluations alongside multinational clinical trials. The publications indicate Gnanasakthy has extensive experience in analyzing patient-reported outcomes and health economics data from clinical trials.
This document discusses ongoing advances and improvements in molecular testing for cancer patients. It summarizes a meeting between clinicians and administrators to discuss these topics. Key points discussed include: evolving guidelines for NSCLC molecular testing, debates around broader molecular profiling for NSCLC, partnerships between community cancer programs and academic research centers, education of staff and patients on molecular testing, ensuring adequate biopsy samples for testing, and initiatives to better evaluate the value of cancer treatments and molecular tests.
ISSN 2321 – 9602
It appears that you are providing information about the publication process of IAJAVS International Journal of Advanced Veterinary and Animal Science. it seems to prioritize a fast publication schedule while maintaining rigorous peer review of the journals in research.
Indo-American Journal of Agricultural and Veterinary Sciences appears to be a reputable journal that values both the speed of publication and the quality of research in the fields of agriculture and veterinary sciences. Researchers interested in submitting their work to this journal of the journalism research.
1) Moffitt Cancer Center provides timely access to a multidisciplinary care team for melanoma patients, allowing diagnosis, staging, and treatment planning to occur in one to two visits. The team reviews pathology reports prior to the first visit to ensure consensus on diagnosis and treatment options.
2) Moffitt streamlines care by having oncologists, dermatologists, surgeons, pathologists, and other providers who are teaching faculty all see patients as part of the comprehensive melanoma care team.
3) Moffitt addresses barriers to care like insurance issues, transportation costs, and travel expenses through dedicated social work support staff to help melanoma patients.
Effectiveness of structured education on safe handling and disposal of chemot...SriramNagarajan16
Aim
To evaluate the effectiveness of structured education on safe handling and disposal of chemotherapeutic drugs among nursing
students
Participants and setting
A pre-experimental one group pre-test – post-test design was adopted for this study. The study was conducted in Vandhana
school of Nursing, Kodhad, telugana, India. The investigator selected 40 nursing students who fulfilled the inclusion criteria
were selected by using simple random sampling technique.
Intervention
Data was collected regarding demographic variable, knowledge and attitude of the diploma in nursing students on safe
handling and disposal of chemotherapeutic drugs.The investigator assessed the level of knowledge and attitude of the
diploma in nursing students by using structured questionnaire and modified three point Likert Scale and by using checklist
through one to one teaching by lecture, demonstration, video clippings and verbalization. Structured teaching programme was
conducted on the same day on group wise each group consists of 17members. Data collection was done in English the
questionnaire was distributed to each nursing students. At the end of the teaching the doubts were cleared. Then 10 minutes
was allotted for discussion.
Measurement and findings
The analysis finding indicates clearly that 36% of students had inadequate knowledge and 46% of them had negative attitude
regarding safe handling and disposal of chemotherapeutic drugs. A well planned structured teaching programme given to the
same group. The effectiveness of programme showed high level of significant at p<0.001 level. It showed that structured
teaching programme was an effective method to improve the knowledge and attitude.
Conclusion
The pharmacist-based interventions improved the knowledge of nursing students in cytotoxic drug handling. Further
assessment may help to confirm the sustainability of the improved practices
This project report summarizes a quantitative analysis of nursing practices related to medication management at XYZ Hospital in Ludhiana, India. The author observed medication administration practices on the hospital's 4th floor over 50 patient cases. The observation found an 18.75% non-compliance rate with best practices, mostly due to staff negligence. Overall, the analysis showed that nursing staff were well-oriented in medication practices, adhering to patients' medication management plans 81.25% of the time. The report recommends continued focus on reducing errors by strictly following medication administration safety guidelines and policies.
This document summarizes the evolution and current state of emergency medicine clinical pharmacists internationally. It describes how their role has expanded from medication distribution to active clinical roles on multidisciplinary teams. Studies show emergency medicine pharmacists can reduce medication errors, mortality, readmissions, and improve time to appropriate treatments. While initially confined to North America, their benefits are now reported internationally. More evidence is still needed on reducing adverse drug events, but existing data shows emergency medicine pharmacists improve patient outcomes and reduce costs.
1) The document discusses improving outcomes and endpoints in cancer trials by better defining what is important to measure, making endpoints more understandable for patients, and advancing endpoints to reflect changes in trial design and treatments.
2) It notes that endpoints need to show clinically relevant benefits to patients, and that improvements in trial design should be accompanied by improvements in available endpoints.
3) Stakeholders including clinicians, patients, and regulators must work together to determine the best approach for research that ensures accountability and optimizes the use of resources.
Conversations About Financial Issues in Routine Oncology Practices: A Multice...Melissa Paige
"We performed qualitative thematic analysis of 529 unique patient encounters from two National Cancer Institue-designated cancer centers and an academic-led county safety-net hospital that were audio recorded prospectively during a three-site communication study"
Use of complementary and alternative medicine by cancer patients at the Unive...home
CAM use is common among cancer patients in Nigeria. Most users do not obtain the
expected benefits, and adverse events are not uncommon. Every clinician in the field of oncology
should ask his/her patients about the use of CAM; this knowledge will enable them to better
counsel the patients
This study assessed the use of complementary and alternative medicine (CAM) among patients in India with four chronic diseases: epilepsy, HIV, rheumatoid arthritis, and diabetes. The researchers surveyed over 4,600 patients and found that 34.7% used CAM. CAM use was highest among diabetes patients (63%) and lowest among epilepsy patients (7.7%). Ayurveda was the most commonly used CAM therapy. The study also assessed patient satisfaction with CAM and found the highest satisfaction for effectiveness and overall among HIV patients, and the lowest among rheumatoid arthritis patients. A large proportion of patients with chronic diseases in India are using CAM and are satisfied with it.
10 STRATEGIC POINTS 2
Ten Strategic Points
Grand Canyon University
DNP-815- O502: Scientific Underpinnings
10 Strategic Points Table
(Use this table to complete the 10 Strategic Points document for your project.)
10 Strategic Points
Comments/Feedback
Broad Topic Area
Impact of Medication Administration Errors on 3-4-Year-old Leukemia Patients
Literature Review
A. Verghese, A., Charlton, B., Kassirer, J. P., Ramsey, M., & Ioannidis, J. P. (2015). Inadequacies of physical examination as a cause of medical errors and adverse events: a collection of vignettes. The American journal of medicine, 128(12), 1322-1324.
The article looks at the “Inadequacies of physical examination as a cause of medical errors and adverse events: a collection of vignettes” from the American journal of medicine. It takes into consideration the fact that, the oversights in the corporeal assessment are a medical fault which aren’t studied via chart evaluation. Furthermore, the article states that these oversights in the corporeal assessments may be the primary contributors to the neglected or late diagnosis besides unnecessary exposure to contrast as well as radiation on the Leukemia patients. Either the authors indicate that the incorrect treatments resulting from these delays leads to unfavorable results like fainting on the Leukemia patient, lack of appetite on the side of the patient, worsening the Leukemia conditions which eventually can lead to early death of the patient.
B. Hockings, J. K., Owolabi, D. K., Broyles, J. E., & Wheelis, S. C. (2017). Impact of medication administration error on over 3 years Leukemia patients and the stimulating factors in acute leukemia and stem cell transplant patients. Supportive Care in Cancer, 25(6), 1853-1858.
The authors of this article explored the “Impact of medication administration error on over 3 years Leukemia patients and the stimulating factors in acute leukemia and stem cell transplant patients.” This article is from supportive care in cancer and it was retrieved from Google Scholar. The article authors acknowledge the fact that, the medication administration errors lead to severe impacts on the health conditions of the patient more especially the ones who are 3 – 4 years of Leukemia. According to the authors, the impacts associated with the medication administration errors may lead to worsening of the health condition of the patient, the rate of Leukemia advancement into higher stages may also increase with treatment or managing of this deadly disease being more complicated. The authors argue that using erroneous medicines, the Leukemia advancement increases without the knowledge of the patient which makes even the survival chances of the patient to reduce due to stress upon realizing that there was an error in his or her medication.
C. Douer, D. (2016). Efficacy and safety of vincristine sulfate liposome injection in the treatment of adult acute lymphocytic leukemia. The oncologist, 21(7), 840-847.
...
A Study on Patient Satisfaction towards Cancer Hospitalijtsrd
A cancer diagnosis places considerable stress on patients and their families. They find themselves discomfort with the strange health system making serious decisions with long term consequences living with uncertainness about the nature, cause and indefinite progress of the disease living with a disrupted family, work, social life and facing the possibility of becoming increasingly dependent on others. Dhivya. S | Harshath. S "A Study on Patient Satisfaction towards Cancer Hospital" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-6 , October 2019, URL: https://www.ijtsrd.com/papers/ijtsrd29274.pdf Paper URL: https://www.ijtsrd.com/management/consumer-behaviour/29274/a-study-on-patient-satisfaction-towards-cancer-hospital/dhivya-s
Observational research can impact clinical decision making for cancer treatment by providing real-world evidence to complement randomized controlled trials, which have limitations. Observational studies capture long-term outcomes of various treatments in everyday practice. However, their findings are more susceptible to bias. To strengthen observational research, standards are needed for electronic health data collection and reporting, while prioritizing patient privacy and rigorous methodologies. With these improvements, observational data can better inform estimates of cancer progression and treatment effects.
This document describes the development and validation of a clinical knowledge measurement tool to assess community pharmacists' ability to detect and resolve drug-related problems (DRPs). The tool consists of 9 clinical cases with multiple choice questions. It was administered to pharmacy students and community pharmacists in Australia. The tool showed good internal consistency and differentiated knowledge levels between student year groups as expected. Pharmacists' scores also correlated with their actual rate of documenting clinical interventions in practice, indicating the tool is effective at estimating pharmacists' ability to detect and resolve DRPs.
Knowledge and attitudes towards complementary and alternative medicine among ...home
The document summarizes a study that examined medical students' knowledge and attitudes toward complementary and alternative medicine (CAM) in Turkey. The study found that the majority of the 943 medical students surveyed were familiar with common CAM methods like herbal treatment, acupuncture, and massage. Most students had positive attitudes toward CAM and expressed willingness to receive training in it. Attitudes declined as students progressed in their medical education. Overall, there was support for integrating CAM into the medical curriculum in Turkey.
Skin Cancer Screening
IMPORTANT NOTE TO USERS OF WEBSITE & DOCUMENTS POSTED ON SLIDESHARE- Global Medical Cures™ does not offer any medical advice, diagnosis, treatment or recommendations. Only your healthcare provider/physician can offer you information and recommendations for you to decide about your healthcare choices.
www.globalmedicalcures.com
Participation of the population in decisions about their health and in the pr...Pydesalud
Póster presentado por Lilisbeth Perestelo en el congreso Summer Institute for Informed Patient Choice (SIIPC14) celebrado del 25 al 27 de junio de 2014 en Dartmouth, Hanover (EEUU). Web: http://siipc.org
Contacto: lperperr@gobiernodecanarias.org
The survey of over 2,800 undergraduate students at UC Irvine found:
1) 35% had used some form of CAM in the past 12 months, and over 90% believed CAM can be effective. However, only 31% had received prior education on CAM.
2) The most common CAM therapies used were supplements, massage, body movement like yoga, herbal medicine, and traditional Chinese medicine.
3) Factors associated with higher CAM use included being female, Asian ethnicity, and having prior CAM education. Most students said they would be interested in CAM courses if they fulfilled graduation requirements or were in their major.
4) The study supports that education is a key factor in CAM use decisions
Objective: To evaluate the utility of a targeted lecture in improving FP awareness amongst clinicians.
Design: This is a dual institution, prospective survey-based study assessing if an educational lecture can increase the likelihood of FP consideration, discussion, and referral.
This document lists publications by Ari Gnanasakthy related to patient-reported outcomes in clinical trials and health economics evaluations. It includes 22 publications ranging from 2005 to 2010 related to establishing minimally important differences in patient-reported outcomes, developing guidance for collecting patient-reported data, evaluating the cost-effectiveness of drugs like valsartan and rivastigmine, and methods for conducting economic evaluations alongside multinational clinical trials. The publications indicate Gnanasakthy has extensive experience in analyzing patient-reported outcomes and health economics data from clinical trials.
This document discusses ongoing advances and improvements in molecular testing for cancer patients. It summarizes a meeting between clinicians and administrators to discuss these topics. Key points discussed include: evolving guidelines for NSCLC molecular testing, debates around broader molecular profiling for NSCLC, partnerships between community cancer programs and academic research centers, education of staff and patients on molecular testing, ensuring adequate biopsy samples for testing, and initiatives to better evaluate the value of cancer treatments and molecular tests.
ISSN 2321 – 9602
It appears that you are providing information about the publication process of IAJAVS International Journal of Advanced Veterinary and Animal Science. it seems to prioritize a fast publication schedule while maintaining rigorous peer review of the journals in research.
Indo-American Journal of Agricultural and Veterinary Sciences appears to be a reputable journal that values both the speed of publication and the quality of research in the fields of agriculture and veterinary sciences. Researchers interested in submitting their work to this journal of the journalism research.
ISSN 2347-2251
Manuscripts should be carefully checked for grammatical and punctuation errors. All papers undergo peer review. Please note that all articles published in this journal represent the opinions of the authors and do not necessarily reflect the official policy of the Journal of Indo-American Journal of Pharma and Bio Sciences of the journals to publish paper.
Scientific development is an ever-evolving journey, driven by the exchange of data and ideas among researchers across the globe.One such remarkable publication dedicated to facilitating this exchange within the fields of Pharmacy and Bio Sciences is the Indo-American Journal of Pharma and Bio Sciences of the published research.
It appears that you have provided information about the "Indo-American Journal of Agricultural and Veterinary Sciences" . This journal seems to be an international online publication in English, published quarterly. It emphasizes fast publication while maintaining a rigorous peer-review process of the published research.
The document summarizes a study on the effects of feed additives HammecoTox and Zeolitis on rats experiencing experimental fumonisin toxicosis. Rats were divided into 4 groups, with groups 2-4 experiencing fumonisin toxicosis and groups 3-4 additionally receiving one of the feed additives. Clinical signs of toxicosis emerged by day 14 in group 2 rats. Hematological analysis on day 14 found increased white blood cells and shifts in leukocyte composition in group 2, indicating inflammation and reduced immunity. After 21 days of feed additive treatment, groups 3 and 4 showed stabilization of hematological parameters and signs of organ recovery compared to group 2. Both additives were found effective in counter
The Indo-American Journal of Agricultural and Veterinary Sciences appears to be a scholarly journal focused on publishing research within the fields of agriculture and veterinary sciences of the journal publishers.
ISSN 2347-2251
Manuscripts should be carefully checked for grammatical and punctuation errors. All papers undergo peer review. Please note that all articles published in this journal represent the opinions of the authors and do not necessarily reflect the official policy of the Journal of Indo-American Journal of Pharma and Bio Sciences of the journal for research.
It seems like you're providing information about the publication process of the International Journal of Advanced Publication Practices. This information outlines the fast publication schedule and peer-review process by the journal of the appears to prioritize a fast and efficient publication process while maintaining the quality and integrity of the research it publishes of the original research papers.
Indo-American Journal of Agricultural and Veterinary Sciences .It sounds like the journal you're referring to has a broad scope covering various aspects of Agricultural Sciences and Veterinary Medicine. The topics listed indicate a comprehensive range of fields within these discipline and submitting manuscripts to this journal can explore research and review articles of the journalism research.
This document summarizes a study that evaluated the knowledge, attitudes, and practices of oncology health professionals in Australia regarding complementary and alternative medicine (CAM). The study surveyed 99 oncology physicians, nurses, and pharmacists. It found that the professionals had moderate knowledge of CAMs but felt unprepared to advise patients due to a lack of expertise. While they acknowledged potential benefits of CAMs, they also expressed safety concerns. Fewer than 40% of patients were open to discussing CAMs with their providers, hindered by a lack of scientific evidence and guidelines. The study reveals a need for more CAM education for oncology clinicians to improve patient-provider discussions and decision-making regarding CAM use.
This document discusses adaptive filtering techniques, specifically the Least Mean Square (LMS) and Recursive Least Squares (RLS) algorithms. It describes the basic structure and operation of adaptive filters, including their use of error signals as feedback to optimize transfer functions. The LMS algorithm is commonly used due to its computational simplicity, while RLS provides faster convergence but with higher complexity. The document proposes a modified Delayed LMS (DLMS) adaptive filter architecture to reduce adaptation delay by feeding error computations forward through pipeline stages. Simulation results show this DLMS design achieves lower area, delay and power compared to conventional LMS and RLS filters.
Scientific development is an ever-evolving journey, driven by the exchange of data and ideas among researchers across the globe.One such remarkable publication dedicated to facilitating this exchange within the fields of Pharmacy and Bio Sciences is the Indo-American Journal of Pharma and Bio Sciences of the journals to publish paper.
It appears that you have provided information about the "Indo-American Journal of Agricultural and Veterinary Sciences" . This journal seems to be an international online publication in English, published quarterly. It emphasizes fast publication while maintaining a rigorous peer-review process of the journal for research.
Indo-American Journal of Agricultural and Veterinary Sciences". It appears to be an international online journal that publishes research and review articles in English on topics related to agriculture and veterinary sciences is the journal of the research publish journal.
The Indo-American Journal of Agricultural and Veterinary Sciences appears to be a scholarly journal focused on publishing research within the fields of agriculture and veterinary sciences of the journals in research.
The Indo-American Journal of Pharma and Bio Sciences is an online international journal that publishes articles quarterly.It's important to note that the specific policies, guidelines, and the editorial board of IAJPB may change over time, so it's advisable to visit the journal's official website or contact the journal of the materials science journal.
The Indo-American Journal of Pharma and Bio Sciences is an online international journal that publishes articles quarterly.It's important to note that the specific policies, guidelines, and the editorial board of IAJPB may change over time, so it's advisable to visit the journal's official website or contact the journal of the research on journaling.
ISSN 2347-2251
Manuscripts should be carefully checked for grammatical and punctuation errors. All papers undergo peer review. Please note that all articles published in this journal represent the opinions of the authors and do not necessarily reflect the official policy of the Journal of Indo-American Journal of Pharma and Bio Sciences of the all journal.
Indo-American Journal of Agricultural and Veterinary Sciences appears to be a reputable journal that values both the speed of publication and the quality of research in the fields of agriculture and veterinary sciences. Researchers interested in submitting their work to this journal of the journal research paper.
Best practices for project execution and deliveryCLIVE MINCHIN
A select set of project management best practices to keep your project on-track, on-cost and aligned to scope. Many firms have don't have the necessary skills, diligence, methods and oversight of their projects; this leads to slippage, higher costs and longer timeframes. Often firms have a history of projects that simply failed to move the needle. These best practices will help your firm avoid these pitfalls but they require fortitude to apply.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.AnnySerafinaLove
This letter, written by Kellen Harkins, Course Director at Full Sail University, commends Anny Love's exemplary performance in the Video Sharing Platforms class. It highlights her dedication, willingness to challenge herself, and exceptional skills in production, editing, and marketing across various video platforms like YouTube, TikTok, and Instagram.
Understanding User Needs and Satisfying ThemAggregage
https://www.productmanagementtoday.com/frs/26903918/understanding-user-needs-and-satisfying-them
We know we want to create products which our customers find to be valuable. Whether we label it as customer-centric or product-led depends on how long we've been doing product management. There are three challenges we face when doing this. The obvious challenge is figuring out what our users need; the non-obvious challenges are in creating a shared understanding of those needs and in sensing if what we're doing is meeting those needs.
In this webinar, we won't focus on the research methods for discovering user-needs. We will focus on synthesis of the needs we discover, communication and alignment tools, and how we operationalize addressing those needs.
Industry expert Scott Sehlhorst will:
• Introduce a taxonomy for user goals with real world examples
• Present the Onion Diagram, a tool for contextualizing task-level goals
• Illustrate how customer journey maps capture activity-level and task-level goals
• Demonstrate the best approach to selection and prioritization of user-goals to address
• Highlight the crucial benchmarks, observable changes, in ensuring fulfillment of customer needs
Industrial Tech SW: Category Renewal and CreationChristian Dahlen
Every industrial revolution has created a new set of categories and a new set of players.
Multiple new technologies have emerged, but Samsara and C3.ai are only two companies which have gone public so far.
Manufacturing startups constitute the largest pipeline share of unicorns and IPO candidates in the SF Bay Area, and software startups dominate in Germany.
Recruiting in the Digital Age: A Social Media MasterclassLuanWise
In this masterclass, presented at the Global HR Summit on 5th June 2024, Luan Wise explored the essential features of social media platforms that support talent acquisition, including LinkedIn, Facebook, Instagram, X (formerly Twitter) and TikTok.
Navigating the world of forex trading can be challenging, especially for beginners. To help you make an informed decision, we have comprehensively compared the best forex brokers in India for 2024. This article, reviewed by Top Forex Brokers Review, will cover featured award winners, the best forex brokers, featured offers, the best copy trading platforms, the best forex brokers for beginners, the best MetaTrader brokers, and recently updated reviews. We will focus on FP Markets, Black Bull, EightCap, IC Markets, and Octa.
B2B payments are rapidly changing. Find out the 5 key questions you need to be asking yourself to be sure you are mastering B2B payments today. Learn more at www.BlueSnap.com.
Storytelling is an incredibly valuable tool to share data and information. To get the most impact from stories there are a number of key ingredients. These are based on science and human nature. Using these elements in a story you can deliver information impactfully, ensure action and drive change.
Structural Design Process: Step-by-Step Guide for BuildingsChandresh Chudasama
The structural design process is explained: Follow our step-by-step guide to understand building design intricacies and ensure structural integrity. Learn how to build wonderful buildings with the help of our detailed information. Learn how to create structures with durability and reliability and also gain insights on ways of managing structures.
Company Valuation webinar series - Tuesday, 4 June 2024FelixPerez547899
This session provided an update as to the latest valuation data in the UK and then delved into a discussion on the upcoming election and the impacts on valuation. We finished, as always with a Q&A
IMPACT Silver is a pure silver zinc producer with over $260 million in revenue since 2008 and a large 100% owned 210km Mexico land package - 2024 catalysts includes new 14% grade zinc Plomosas mine and 20,000m of fully funded exploration drilling.
How MJ Global Leads the Packaging Industry.pdfMJ Global
MJ Global's success in staying ahead of the curve in the packaging industry is a testament to its dedication to innovation, sustainability, and customer-centricity. By embracing technological advancements, leading in eco-friendly solutions, collaborating with industry leaders, and adapting to evolving consumer preferences, MJ Global continues to set new standards in the packaging sector.
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challengesHolger Mueller
Holger Mueller of Constellation Research shares his key takeaways from SAP's Sapphire confernece, held in Orlando, June 3rd till 5th 2024, in the Orange Convention Center.
Event Report - SAP Sapphire 2024 Orlando - lots of innovation and old challenges
ugc carelist journals
1.
2. ISSN 2347-2251 www.iajpb.com
Knowledge, attitudes, and practices of oncology health
professionals on complementary medicines
P. Ershad Khan, P. Nishad Khan, Dr. C. S. Parameswari
Abstract
Context: About 50% of cancer patients use some kind of CAM, raising worries about possible drug interactions with standard cancer therapy. This
research aimed to investigate oncology staff members' CAM knowledge, attitudes, and behaviors in order to better understand how they may
contribute to the safe use of these therapies.
The purpose of this research was to evaluate the CAM knowledge, attitudes, and behaviors among oncology professionals in Australia.
MethodsThree national oncology professional organizations' members were surveyed through online questionnaire to assess their familiarity
with, and comfort with using, complementary and alternative medicine (CAM). Nine physicians, seventy nurses, and twenty pharmacists
responded to the survey, for a total of 99 completed forms. Sixty-eight point four percent of those polled felt unprepared to answer patients'
inquiries about CAMs because of a lack of expertise about the topic. Respondents, on the whole, agreed that CAMs play a supplementary function
in oncology, however they voiced certain safety concerns. The respondents said that fewer than 40% of their patients would be open to discussing
complementary and alternative medicine (CAM), with the absence of scientific evidence and guidelines for CAM usage being major hurdles to such
talks. Our research reveals that a lack of awareness of CAMs among cancer health professionals may cause them to be less confident when
advising patients and raises concerns about patient safety. This affects the way they talk about CAMs with patients and may explain why some
people don't tell their doctors they use CAMs. Education on CAMs in oncology would help raise clinicians' confidence in addressing these
treatments, leading to more patient disclosure of CAMs and safer treatment decision making for persons with cancer.
Keywords: knowledge, attitudes, practices, complementary and alternative medicine, oncology.
INTRODUCTION
The number of cancer patients who turn to CAM
(complementary and alternative medicine) has
increased during the last several decades. Twenty-five
percent of persons with cancer undergoing treatment
employed these methods prior to the 1990s. 1 Among
the previous decade, the use of CAM has climbed to an
average of 51% of patients2, with usage being more
prevalent in people with cancer than the general
population. 3
Given its prevalence, there is cause for worry over the
safety of standard anticancer therapy. Antiplatelet
activity observed in garlic and turmeric4 are examples
of biologically based CAMs that might impact bleeding
risk, and they may also modify the pharmacokinetics of
chemotherapy. agents. In the second scenario, the
therapeutic efficacy may be diminished, and the risk of
adverse effects and toxicity may rise. 5,6 In addition,
over half of cancer patients are not revealing CAM
usage to their physicians due to the doctors' apparent
lack of interest, understanding, or permission. 7
Considering their prevalence, it is important to learn
how oncology doctors now view CAMs. Two systematic
reviews of oncologists' and nurses' (or nurses') CAM
knowledge, attitudes, and practices (KAP) have been
published so far8 and 9, respectively. In most cases,
doctors and nurses were found to be woefully
uninformed about CAMs. Pharmacists were found to be
more neutral, while nurses were found to be more
encouraging of their patients' use of CAMs, while
oncologists and other physicians were shown to be more
likely to oppose CAM Process of integrating
complementary and alternative medicine
(CAM) into standard care.
8 Both evaluations, however, noted that heterogeneity in
KAP study designs prevented them from drawing any
firm conclusions. 8,9
Pharmaceutics
Dr.K.V. Subba Reddy Institute of Pharmacy
(Approved by AICTE,P.C.l New Delhi& Permanently Affiliated to JNTUA Anantapuramu
MOU with Government General Hospital &KMC, K urnool
3. In addition, previous studies conducted over the last
decade have either examined the KAPs of many
professions collectively (as in study 10) or have zeroed in
on the KAPs of a single profession.
8,11,12 Only one research was found that compared the
KAPs of various health professionals; Stub et al.13
examined the KAPs of Norwegian doctors, nurses, and
CAM practitioners with regards to CAM usage in cancer;
this study was published in 2018. The results of this
research indicate that medical professionals who have not
had formal CAM training are wary of their patients using
CAMs and are reluctant to have conversations with them
about the topic. This contradicts the findings of
complementary and alternative medicine (CAM)
practitioners and health professionals with formal
training in CAM treatments13, demonstrating that CAM
expertise may influence CAM-related attitudes and
behaviors.
This research seeks to be the first of its kind to examine
the KAPs of oncology physicians, nurses, and
pharmacists in Australia in regards to CAM use by cancer
patients.
METHOD
Individuals in the Sample
In Australia, oncology professionals made up the bulk
of this study's sample cohort. Three groups in
particular were involved: the Clinical Oncology
Society of Australia (COSA), the Cancer Nurses
Society of Australia (CNSA), and the Oncology and
Haematology Interest Group of the Society of Hospital
Pharmacists of Australia (SHPA) (SHPA). There are a
total of 2923 members of the COSA14 and CNSA15,
as reported in their yearly reports and corroborated by
SHPA. All active oncology physicians, nurses, and
pharmacists who are members of relevant professional
organizations were eligible to take part. No restrictions
were placed on participants based on their level of
oncology expertise or number of years in the field.
Study Tool Design
The definition of CAMs used in this study is taken from
the National Centre for Complementary and Integrative
Health (NCCIH). They classify CAMs into three
natural products, which includes herbs and
vitamins, and mind and body prac- tices, which
includes physical therapies and mindfulness
techniques like meditation and yoga; and other
com- plementary health approaches, which
comprises tradi- tional health systems and those
not in the other categories, such as Ayurveda,
traditional Chinese medi- cine, and homeopathy.
16
An online questionnaire was used to gather
information on people's beliefs, expectations, and
experiences with CAM for cancer treatment. With
their permission, we predominantly used the
survey produced by Lee et al.17 in their 2014 work
that studied the KAPs of American oncologists on
herbal supplements in oncology. The first part of
the questionnaire consisted of 10 multiple-choice
questions designed to test respondents' familiarity
with the topic of complementary and alternative
medicine (CAM) interactions with cancer
medicines and CAM indications in oncology.
The second part of the survey measured
participants' opinions by having them rate how
much they agreed with statements on the use of
CAM in oncology on a five-point Likert scale. As
part of the survey, participants were asked to rate
how crucial it was to bring up patient and
treatment-related aspects while discussing CAMs
with patients.
Practitioners were asked what proportion of their
patients they thought were using CAMs, what
proportion of their patients they had discussed
CAMs with, and what proportion of those
conversations they had started in the final phase of
the questionnaire analyzing practices. In addition,
respondents were asked to share their experiences
with supporting patients' use of CAMs and to
name any obstacles they've encountered when
bringing up the topic with their patients. While
using a Likert scale, we choose the most common
response to represent the population's norm when
answering the question.
The respondents were questioned in Section 4
whether they had any CAM training throughout
their undergraduate studies. After that, they were
asked about their demographics, including their
age, gender, greatest level of education, and
current occupation. Twenty-one medical
professionals at Townsville University Hospital
were used in a pilot study to examine the
questionnaire for clarity and accuracy. The results
from the trial run were discarded before the full
analysis was performed.
The use of SurveyMonkey for the dissemination of
the questionnaires was a convenient and reliable
method (Momentive, Waterford, NY, USA). A
survey was sent out to members of the COSA and
CNSA via their designated survey administrators,
and members of the SHPA Oncology and
Haematology Inter- est Group were able to
participate in the survey using the group's online
forum.
users are presented with a URL and encouraged to take
part in the study. This was a link to a website that
provided background on the study and survey.
Participants who gave their informed consent were sent
to a web-based survey. Two months later, we remem-
bered everyone in each group by email. Between
February 2021 and October 2021, you might fill out this
survey.
Statistics and Data Collection
4. In order to conduct statistical analysis, data from the
SurveyMonkey website were downloaded into a
Microsoft Excel (Microsoft Corporation, Red- mond, WA,
USA) spreadsheet and then imported into SPSS Version
25 (IBM Corp, Armonk, NY, USA). When comparing the
overall replies to those of physicians, nurses, and
pharmacists, we used chi-square tests and independent t-
tests to establish statistical significance.
RESULTS
A total of 127 persons gave their permission to be studied
during recruiting. Seventeen people didn't bother to
answer any of the questions. The remaining 11
respondents either did not complete the questionnaire or
did not provide their occupation. The final tally of
questionnaires analyzed was 99. This would enable
results to be reported with a 95% confidence level and a
9.68% margin of error, based on the total memberships of
the professional organizations that were surveyed.
There were nine medical physicians, seventy nurses, and
twenty pharmacists in this group. Table 1 displays the
results of our demographic survey. The majority of
respondents were women with advanced degrees in the
medical field. Doctors had a more equitable gender split
than other medical professionals (55.6% male, 44.4%
female; p 0.001 vs. 2.9% male, 97.1% female in the nursing
sector).
Knowledge
Ten multiple-choice questions were used to test students'
familiarity with the concepts of CAM interactions with
conventional cancer therapy and CAM indications in
cancer care. The majority of responders had scores
between 3 and 4. Separated by occupation, the average
score for physicians was 4.6, the average score for nurses
was 3.4, and the average score for pharmacists was 5.8. It
was revealed that pharmacists had a significantly higher
score than nurses (p 0.001, data not provided).
Attitudes
Responses to statements on the use of CAMs in oncology
were used to gauge respondents' opinions, as shown in
Figure 1. The majority of respondents (68.7%) did not
think that their cultural or religious views influenced
their perspective on CAMs, and the majority (74.4%), did
not accept that CAMs had anticancer qualities. Nearly
seventy-two percent of those polled didn't think they
knew enough about CAMs to correctly answer questions
regarding them. The majority of people (58.6%) agreed
that CAMs might assist with side effects of cancer
therapy, and the majority (71.8%) and the majority
(63.6%) agreed that CAMs had favorable benefits on
psychological (71.8%) and physical (63.6%) symptoms.
Eighty-four percent of respondents said they would back
a patient's use of CAMs if none better were available, but
more than three-quarters (78.8%) agreed that patients
spend too much money on CAMs. As a final point, 92.9%
of those who took the survey expressed worry about
possible negative interactions between CAMs and
anticancer therapies.
A higher percentage of pharmacists (75% vs. 20.2% &
22.0%, respectively, p 0.001 & p = 0.004) reported feeling
confident in their ability to answer patients' inquiries
about CAMs. Nurses were more optimistic than
pharmacists (71.4 percentage points) regarding the
efficacy of CAMs in reducing adverse effects.
Table 1 Participant demographic data
Frequency (%)
Doctors,
frequency (%)
Nurses,
frequency (%)
Pharmacists,
frequency (%)
Gender
Male 14 (14.1%) 5 (55.6%) 2 (2.9%) 7 (35%)
Female 84 (84.8%) 4 (44.4%) 68 (97.1%) 12 (60%)
Prefer not to say 1 (1%) 0 0 1 (5%)
Highest education level
Health-related Postgraduate degree 48 (48.5%) 4 (44.4%) 34 (48.6%) 10 (50%)
Research-related postgraduate degree 8 (8.1%) 3 (33.3%) 4 (5.7%) 1 (5%)
Graduate diploma and graduate certificate 27 (27.3%) 0 24 (34.3%) 3 (15%)
Bachelor’s degree 16 (16.2%) 2 (22.2%) 8 (11.4%) 6 (30%)
5. Figure 1 Responses to attitude-related statements.
nurses vs 20% of pharmacists, p 0.001), alleviating
psychological symptoms (78.5% versus 40% of
pharmacists, p 0.001), and relieving physical problems
(76.3 versus 25% of pharmacists, p 0.001).
Respondents were then asked to indicate the relevance of
several aspects when discussing CAMs with patients in
the last half of this section. All respondents ranked the
safety of CAMs as either "most essential" or "very
important," making it clear that this is the issue that
stands out most. Patients' preferences (93.4%), clinical
experience (85.7%), and CAMs' efficacy (84.9%) followed
in order of importance.
Practices
First, we looked at how many patients respondents said
they had discussed CAMs with and how many patients
they estimated really used them (summarized in Table 2).
There was a correlation between the number of patients
that doctors thought were using CAMs and the number
of patients that they discussed CAMs with. Only about a
third of the time did medical professionals even start the
conversation about complementary and alternative
medicine.
Respondents stated they would reply as follows during
CAM talks with patients:
would be most inclined to support their patients’
CAM use (82.8% would often or sometimes
support) than dis- courage (70.4%) or remain
neutral (63.9%). Recommend- ing CAM was close
31.0
35.9
26.8
40.6
20.6
41.8
In the past 12 months what
is the percentage of your patients
or customers with a diagnosis
of cancer that currently
use CAM? (98 respondents)
In the past 12 months, with
approximately what percentage of
your patients or customers
with a diagnosis of cancer have
you discussed the topic of
CAM? (97 respondents)
Please estimate what percentage
of these discussions
about CAM were initiated
by you (90 respondents)
Table 2 Self-estimated practice patterns of respondents
Standard
Mean deviation
6. to evenly divided among all health professionals
(52.5% would often or sometimes recom- mend,
data not shown).
KAP on CAM by oncology professionals
Table 3 Barriers to discussion of CAM use with people with
cancer by all health professionals
Frequency Percentage
Do not believe in CAMs 14 14.3%
Limited time during consultation 32 32.7%
No interest in using CAMs 12 12.2%
Lack of scientific data on 78 79.6%
safety and efficacy
Lack of professional/hospital guidelines 63 64.3%
Other 18 18.4%
As can be seen in Table 3, there are certain medical
professionals that feel uncomfortable bringing up
complementary and alternative medicine (CAM) with
their patients. Lack of professional or hospital guidelines
(64%) and a lack of scientific evidence on safety and
efficacy (79.6%) were the two most common obstacles.
Education
Almost three quarters of participants (71.7% to be exact)
said that they had not gotten any knowledge on CAM in
their undergraduate degree. There was a statistically
significant difference between pharmacists (65%) and
nurses (18.6%, p 0.001, data not shown) in terms of the
percentage of respondents who reported having CAM
education.
DISCUSSION
This research surveyed oncology professionals in
Australia to ascertain their familiarity with
complementary and alternative medicine (CAM) and
their perspectives on its role in cancer treatment. Overall,
health care providers scored below 50% on the
knowledge evaluation and were unprepared to address
patients' inquiries concerning CAMs. The results of the
survey indicated that respondents thought CAMs may
complement conventional therapy. They did, however,
express worries regarding the security of CAMs. Most
health professionals claimed they were likely to support
their patients' use of CAMs, but less than half said they
had brought the topic up with their patients. Lack of
scientific proof regarding safety and efficacy was seen as
the greatest barrier to discussing these medicines with
patients.
consistent with the study's other results, which showed
that pharmacists were more likely to obtain training in
CAMs as part of their undergraduate curriculum than
nurses were. These findings point to the critical need of
CAM training for practitioners.
In a survey of American oncologists, Lee et al.17 reported
that when asked about herbal supplements' potential
interactions with standard cancer therapy, doctors gave
an average score of 1.8 out of 4 (45%). With our average of
the physicians' responses at 46%, this is in line with their
findings. In contrast to our finding of an average of 58%
from pharmacists, Harnett et al.18, who surveyed
Australian community and hospital pharmacists about
their KAPs toward CAM and cancer, found an average
score of 10 out of 16 (63%). The time difference in issue
may explain this mismatch. The absence of
standardization in questionnaires and the style of
knowledge evaluation (self- assessment vs. testing)
hinders the comparability of research, as was shown in
the systematic KAP review of health professionals. 8
The Effect of Information on Opinions
More over two-thirds of respondents felt they did not
know enough about CAMs to address their patients'
inquiries, despite the knowledge ratings. This indicates
that most medical professionals feel unprepared to
discuss complementary and alternative medicine with
their patients.
Respondents' concerns about the safety of CAM usage in
cancer were evident, and this may have an effect on
professionals' perspectives. Concern regarding
interactions was shared by over 90% of respondents, and
69.7% of those polled did not feel that CAMs are safe.
When asked about CAMs, most respondents agreed that
safety comes first. Finally, the most often identified
hurdles to CAM conversations were a lack of evidence on
safety and efficacy. It was also found in the health
professions evaluation that medical professionals were
worried about the side effects and interactions that may
occur while using CAM treatments alongside traditional
medicine. 8 These results suggest that future training
efforts should concentrate on ensuring that professionals
in these fields are adequately educated about the safety of
CAMs for persons with cancer. Furthermore, it implies
causality with the knowledge section results. Most
respondents felt unprepared to address CAMs with their
patients, which may translate to a more cautious outlook
on the topic of safety. The qualitative interviews with
oncologists and patients that Broom et al.19 conducted
in for cancer nurses to have conversations about CAMs
with their patients. Our recommendations are supported
by their observation that inexperience leads to a cautious
approach to CAM usage because of the possibility of
unintended consequences.
We also discovered that our respondents had
conservative views on the prevalence of CAMs, with an
average estimate of CAM use among their patients of
41.8%. When comparing the three professions, this was
greater than the estimated range of 25%-40% of patients
by physicians. 8 A 2019 systematic analysis, however,
indicated that CAMs were used by an average of 51% of
cancer patients worldwide during the preceding decade.
2 This shows that medical practitioners often
underestimate the prevalence of CAM use among their
patients.
7. When comparing pharmacists and nurses on their
perspectives on CAM's role in oncol- ogy, the former are
more likely to agree that CAMs are useful in treating the
side effects of cancer therapy and the physical and
psychological symptoms of cancer. This is consistent with
the findings from the review of health professionals,
which found that nurses generally supported the use of
CAMs in the treatment of symptoms and side effects,
while half of doctors supported CAM use as a
complementary to conventional treatment and
pharmacists were neutral on the use of CAMs for
symptomatic relief and improvement in quality of life. 8
A majority of our sample of oncologists had mixed
feelings about CAMs' place in the field, although they
were mostly favorable about their potential psychological
benefits. These results are consistent with those found by
a study of Italian hospital professionals conducted by
Beretta et al.11. Half of the oncologists polled thought
CAMs may be useful in cancer treatment. In contrast, a
study conducted by Yang et al.12 among Chinese
oncologists found that 95.3% of oncologists favored
integrative oncology, or the use of CAMs in conjunction
with traditional therapy. Note, however, that over half of
the doctors who filled out the poll considered themselves
integrative medicine practitioners; this might have
skewed the results.
Broom and Adams19, based on interviews, corroborate
our findings by suggesting that nurses are more likely to
use a patient-centered, holistic approach to treatment
when it comes to CAMs. Nurses were seen as more likely
to support a patient's use of CAM than physicians were
by respondents.
Influence on Practices
Responses to the practice section showed a general
trend to be less inclined to engage with patients’
CAM average of 40.6% of patients had a conversation
about complementary and alternative medicine (CAM)
usage. This finding is consistent with the findings of
Powers-James et al.20, who surveyed American
oncologists online and found that respondents
discussed CAMs with 41% of patients on average. The
Italian research by Berretta et al.11, on the other hand,
indicated that oncologists typically discussed
complementary and alternative medicine (CAM) with
49.2% of their patients. Since this was the first
investigation of KAPs in Italian doctors, relating CAM
usage by persons with cancer, the reason for the greater
rate in the later study is not immediately evident.
When looking at all three occupations combined,
an average of 36% of CAM conversations were
started by respondents. This is a little more than
the 25% of responding oncologists who initiated
conversations about CAMs reported by Powers-
James et al.20. This indicates that cancer healthcare
providers may be hesitant to initiate conversations
on CAMs, instead expecting patients to bring up
the topic first. Moreover, this supports the findings
of a comprehensive review of communication of
complementary and alternative medicine (CAM)
usage in cancer treatment, which found that a
primary reason patients did not disclose CAMs to
their health providers was because they had not
been asked. 7
A majority of physicians (63%) and a large majority
of nurses (93%), according to the assessment of
health professionals, are willing to assist patients
who desire to utilize CAMs.
8 Our findings are consistent with this range, with
82.8% of respondents expressing support for CAM
usage on a regular or occasional basis.
Nonetheless, it is worth noting that the second
most common behavior among our questioned
health professionals would be to discourage or stay
neutral towards mixing CAMs with conventional
treatment, suggesting that reactions made by
health professionals might be extremely diverse.
This is further shown by the almost even
splintering of opinion across respondents about
their own recommendation of CAM treatments.
While 57.6% of oncologists would prescribe CAMs,
the assessment of health professionals indicated
that just a small percentage of MDs and RNs
would make such a recommendation to their
patients. 8 It's also worth noting that 84.8% of those
who participated in our survey said they would
support a patient's use of complementary and
alternative medicine (CAM) if conventional
therapies had failed. This wide range of responses
shows that additional study is needed to
characterize how medical professionals interact
with cancer patients who use CAMs.
Weaknesses in the Research
The study had flaws, but then again, so does
any research. There was a disproportionate
lack of physicians and other medical
professionals in this sample. This might have
skewed the comparison between groups and
affected the results for this occupation.
Members were only reminded once to fill out
the survey according to the policies set out by
the COSA and CNSA. As a result, this may have
discouraged prospective volunteers from
taking part in our research..
CONCLUSION
To our knowledge, this is the first research to examine the
similarities and differences between the perspectives of
medical physicians, nurses, and pharmacists in regards to
the use of complementary and alternative medicine
(CAM) in oncology.
Our results imply that cancer health professionals'
knowledge, attitudes, and behaviors toward CAMs are
interconnected. Lack of confidence in addressing CAMs
with patients might be related to poor knowledge or a
perceived lack of awareness about CAMs. This would
cause cautious attitudes toward these therapies,
motivated by worries about their compatibility with
standard medical care. As a consequence, practitioners
may be hesitant to bring up CAMs with patients and may
react differently when patients express interest in or
commitment to CAMs. Filling up the gaps in CAMs'
8. knowledge might have a beneficial effect on people's
perspectives and choices. Health practitioners' comfort
level in discussing CAM usage with cancer patients might
be boosted by the creation of easily available, high-
quality, evidence-based material.
REFERENCES
1 Horneber, Michael; Bueschel, Gerhard; Dennert, Gerhard; Less, Daniel;
Ritter, Edward; Zwahlen, Michael. A comprehensive study and meta-
analysis of the prevalence of complementary and alternative medicine
usage by people with cancer. Int. J. Cancer Ther. 2012; 11: 187-203.
2
Researchers: Keene MR, Heslop IM, Sabesan SS, and Glass BD. Systematic
review of complementary and alternative medicine for cancer.
Supplemental Therapies in Clinical Practice 2019; 35, 33–47.
Thirdly, Rashrash M, Schommer JC, and Brown LM. The prevalence of
and factors associated with the use of herbal medicines among American
adults. 2017;4(Issue 1):108-13 in the Journal of Patient Experience.
4
E. Ben-Arye, N. Samuels, L. Goldstein, K. Mutafoglu, S. Omran, E. Schiff,
and others. Potential dangers of using traditional herbal medicines for
cancer treatment: a survey of Middle Eastern oncology specialists. In 2016,
Cancer was published in 122:598–610.
5
L. Braun and M. Cohen. Natural & Organic Supplements & Herbs: What
the Research Says. Elsevier Australia; 2014. 6th edition. Chatswood, NSW:
Elsevier Australia. S Rockwell, Y Liu, and S A Higgins. The herbal remedy
black cohosh modifies the actions of cancer treatment drugs on breast
cancer cells. 2005;90:233-9 Breast Cancer Research and Treatment.
7
Mullan BA, Clarke S, Oh B, Butow PN, Davis EL. Systematic assessment of
the literature on complementary and alternative medication usage
disclosure and communication between patients and doctors in cancer
care. According to Oncologist, Volume 17, Issue 1475–1481, 2012.
8 Researchers: Keene MR, Heslop IM, Sabesan SS, and Glass BD. A
comprehensive analysis of medical professionals' understanding,
acceptance, and use of CAM for cancer treatment. Journal of Community
Health 2020;13: 205-18.
9 Authors: Cuthbertson, L. A., Abigail W. Christina Educating nurses
about alternative cancer therapies and their perceptions of these
treatments. Asia Pac As of 2016, there have been three issues of the Journal
of Oncology Nursing.
Delaney L.J. and Manley, S.J. How can the knowledge, perspectives,
confidence, and documentation around the use of complementary and
alternative therapies be increased in a regional radiation oncology
treatment center? 11 J Med Radiat Sci. 2019; 66: 191-9. M. Berretta, L.
Rinaldi, R. Taibi, P. Tralongo, A. Fulvi, V. Montesarchio, et al. How
doctors feel about patients using Complementary and Alternative
Medicine
In a group of 12 researchers (Yang G, Zhang H, Xu Y, Zhao A, Shu P,
Wang W, et al. An introduction to integrative oncology in China,
including its history, current state, and future prospects. It will be
published in Integr Cancer Ther on January 20, 2021, with the volume
number 20:153473542110635.
13
T. Stub; S. A. Quandt; T. A. Arcury; J. C. Sandberg; A. E. Kristoffersen.
Conventional and alternative cancer care professionals' perspectives and
understanding of direct and indirect dangers. 2018;18:44 BMC
Complement Altern Med.
Australia's 14-member Clinical Oncology Society (COSA). The 2021
Annual Report of the Council of Social Agencies. Annual Report 2020–
2021, Cancer Nurses Society of Australia (CNSA), Sydney, Australia:
Cancer Outcomes Services Australia (COSA), 2022. 16 National Centre for
Complementary and Integrative Health. Gabbadah, WA: CNSA Australia,
2021. What's in a Name? Comparing Complementary, Alternative, and
Integrative Health. Health Research and Development Administration;
2016. Integrative Health Information Network (NCCIH): https://
nccih.nih.gov/health/integrative-health. Referred to in works cited on or
after May 1, 2018.
17
Lin H, Olopade OI, Melhem-Bertrandt A, Olopade IO, Lee RT, Barbo A,
Lopez G, and others. Examining oncologists' perspectives on the use of
complementary and alternative medicine by cancer patients in the United
States. 2014, Volume 32, Issue 40:4095–101 of the Journal of Clinical
Oncology.
18 Harnett, J., L. Le, L. Smith, I. Krass, and T. Krass. The pharmacist's
perspective on, and familiarity with, complementary medicine usage by
persons coping with cancer. 2018;40(10):1272–80 in the International
Journal of Clinical Pharmacy.
Broom, A., and Adams, J. Reports from oncology professionals who have
had conversations with their patients about CAM. Health (London, 2009);
13:317–36. 20 A. Powers-James, A. Alvarez, K. Milbury, A. Barbo, K.
Daunov, G. Lopez, and C. Powers-James, among others. We oncologists
discuss how our own personal and professional experiences with and
attitudes about complementary and alternative medicine have been
shaped by our spiritual and religious beliefs. 2020;19:153473542094576
Integr Cancer Ther.